Natco Pharma Ltd NSE/BSE Share

Q: How to Buy Natco Pharma Ltd Stock?

<div> Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders. <div> 1. Login to the Kuvera app or website and go to Invest section. </div> <div> 2. Select stocks and search for Natco Pharma Ltd or scroll over to Natco Pharma Ltd </div> <div> 3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction. </div> </div>

Q: What is the Share Price of Natco Pharma Ltd?

<div>The share price of Natco Pharma Ltd stocks is ₹771.65 as on 28/02/2025</div>

Q: What is the Market Cap of Natco Pharma Ltd?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Natco Pharma Ltd stock is ₹13,821.0 Cr on 28/02/2025.</div>

Q: In which sector / industry does Natco Pharma Ltd operate?

<div>Natco Pharma Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.</div>

Q: What was the revenue of Natco Pharma Ltd?

<div>The revenue of Natco Pharma Ltd as of 2023 was ₹3,978.8 Cr</div>

Q: What is the PE ratio of Natco Pharma Ltd?

<div>The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. P/E ratio of Natco Pharma Ltd is 7.41 as on 28/02/2025.</div>

Q: What is the 52 week high price of Natco Pharma Ltd?

<div> The 52 week high of Natco Pharma Ltd stock is ₹1,638.35. </div>

Q: What is the 52 week low price of Natco Pharma Ltd?

<div> The 52 week low of Natco Pharma Ltd stock is ₹757.75. </div>

Q: Can fractional shares of Natco Pharma Ltd be purchased?

<div>No, you cannot buy fractional shares of Natco Pharma Ltd, or any listed Indian company as of now.</div>

Healthcare Drug Manufacturers - Specialty & Generic

₹771.65

-28.15

(28 Feb)

-3.5%

Loading chart

Price

₹771.65

Today’s high

₹792.00

Today’s low

₹757.75

52W high

₹1,638.35

52W low

₹757.75

-23.3%

7.41

1.93

EPS (TTM)

77.34

Dividend yield

0.9%

6.6%

Market cap

₹13,821.0 Cr

Volume

1,75,463

Average volume

58,538

Insights

NATCOPHARM has made a new 52 Wk low. 52 Wk low stocks tend to underperform in the near term.

NATCOPHARM price is below its 200 day moving average

NATCOPHARM PE is in the low end of its range over the past 2 years

NATCOPHARM is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.

In beta. Send feedback here.

Compare with other stock

₹5,462.75

₹1,906.20

₹1,055.35

₹1,593.90

₹1,117.65

₹771.65

-2.6%

+0.8%

-2.3%

-3.3%

-0.7%

-3.5%

+54.4%

+17.5%

+1.0%

+0.7%

-13.3%

-23.3%

70.17

30.40

17.65

33.42

17.37

7.41

10.57

5.56

1.99

5.53

2.93

1.93

77.85

62.70

59.81

47.70

64.34

104.12

Large

Financials

Income statement

Balance sheet

Cash flow

Quarterly

Annual

As of 2023

Revenue

₹3,978.8 Cr

Net income

₹1,388.3 Cr

See stock holdings

Top institutional holders

Aditya Birla Sun Life AMC Ltd

1.67%

Vanguard Group Inc

1.55%

TATA AIA Life Insurance Company Limited

1.26%

Tata Asset Management Limited

1.25%

ICICI Prudential Asset Management Company Limited

1.25%

Top mutual fund holders

Mirae Asset Emerging Bluechip

1.46%

Mirae Asset Large & Midcap Fund

1.46%

Quant Small Cap Fund

1.05%

Tata Equity P/E

0.93%

ICICI Prudential India Opportunities Fd

0.85%

About Natco Pharma

Natco Pharma Ltd is a drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. It derives maximum revenue from Pharmaceuticals Segment.

Company address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, 500034

Company URL

https://www.natcopharma.co.in

Key executives

Name

Title

Age

Mr. Rajeev Nannapaneni

CEO/Director/Vice Chairman of the Board

47 yrs

Mr. Venkaiah Chowdary Nannapaneni

Chairman of the Board/Director/Managing Director

79 yrs

Mr. P.S.R.K. Prasad

Director/Executive VP, Divisional

Dr. Pavan Bhat

Director/Executive VP, Divisional

Mr. Potluri Prasad Sivaramakrishna

Director/Executive VP, Divisional

66 yrs

FAQs

How to Buy Natco Pharma Ltd Stock?

What is the Share Price of Natco Pharma Ltd?

What is the Market Cap of Natco Pharma Ltd?

In which sector / industry does Natco Pharma Ltd operate?

What was the revenue of Natco Pharma Ltd?

What is the PE ratio of Natco Pharma Ltd?

What is the 52 week high price of Natco Pharma Ltd?

What is the 52 week low price of Natco Pharma Ltd?

Can fractional shares of Natco Pharma Ltd be purchased?